This inventor holds 1 USPTO granted patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Geert S J Mannens: Innovator in Cancer Treatment
Introduction
Geert S J Mannens is a notable inventor based in Lier, Belgium. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic methods.
Latest Patents
Mannens holds a patent for "Methods of treating cancer using PRMT5 inhibitors." This patent outlines methods for treating human patients diagnosed with cancer by administering a therapeutically effective amount of a PRMT5 (protein arginine methyltransferase 5) inhibitor. The methods include administering initial doses of at least about 0.1 mg per day of a specific PRMT5 inhibitor for an initial dosing period of about 5 to 21 days, followed by subsequent doses for additional periods.
Career Highlights
Mannens is associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His work focuses on developing innovative treatments that can improve patient outcomes in oncology.
Collaborations
Mannens has collaborated with notable colleagues, including Hillary Joy Millar Quinn and Kathryn Elizabeth Packman, to advance research in cancer therapies.
Conclusion
Geert S J Mannens is a dedicated inventor whose work in cancer treatment exemplifies the importance of innovation in medicine. His contributions continue to pave the way for new therapeutic approaches that can benefit patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile